Anzeige
Mehr »
Samstag, 16.05.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CN4F | ISIN: US0717711099 | Ticker-Symbol: BV3A
Siehe auch BAVARIAN NORDIC A/S
München
15.05.26 | 08:11
8,550 Euro
-0,58 % -0,050
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
BAVARIAN NORDIC A/S ADR Chart 1 Jahr
5-Tage-Chart
BAVARIAN NORDIC A/S ADR 5-Tage-Chart
RealtimeGeldBriefZeit
8,2008,65013:04

Aktuelle News zur BAVARIAN NORDIC A/S ADR Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiBavarian Nordic A/S: Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such4
MiBavarian Nordic A/S Reveals Decline In Q1 Income18
BAVARIAN NORDIC A/S ADR Aktie jetzt für 0€ handeln
MiBavarian Nordic A/S: Bavarian Nordic Announces Interim Results for the First Three Months of 2026332COPENHAGEN, Denmark, May 13, 2026 - Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first three months of 2026. Revenue for the first...
► Artikel lesen
DiBavarian Nordic Raises 2026 Guidance After Additional U.S. Vaccine Order11
MoBavarian Nordic A/S: Bavarian Nordic Awarded Contract Options from the U.S. Government for Production and Supply of Freeze-dried Smallpox Vaccines889Exercised options total USD 97 million, covering manufacturing of bulk vaccine and supply of freeze-dried vaccines.Company upgrades full-year financial guidance COPENHAGEN, Denmark, May 11, 2026...
► Artikel lesen
MoBavarian Nordic A/S: Bavarian Nordic - Completion of Share Buy-Back Program18
04.05.Bavarian Nordic A/S: Bavarian Nordic - Transactions in Connection with Share Buy-Back Program7
27.04.Bavarian Nordic A/S: Bavarian Nordic - Transactions in Connection with Share Buy-Back Program5
21.04.Resolutions of the Annual General Meeting 2026 of Bavarian Nordic A/S292COPENHAGEN, Denmark, April 21, 2026 - Bavarian Nordic A/S (OMX: BAVA) today held the Annual General Meeting with the following results: The Annual Report for 2025 was adopted. The Board of Directors'...
► Artikel lesen
20.04.Bavarian Nordic A/S: Bavarian Nordic - Transactions in Connection with Share Buy-Back Program7
16.04.Bavarian Nordic A/S: Bavarian Nordic Receives Swissmedic Approval for Chikungunya Vaccine544COPENHAGEN, Denmark, April 16, 2026 - Bavarian Nordic A/S (OMX: BAVA) today announced that the Swiss Agency for Therapeutic Products, Swissmedic, has approved VIMKUNYA (recombinant, adsorbed) for active...
► Artikel lesen
13.04.Bavarian Nordic A/S: Bavarian Nordic - Transactions in Connection with Share Buy-Back Program4
07.04.Bavarian Nordic A/S: Bavarian Nordic - Transactions in Connection with Share Buy-Back Program9
30.03.Bavarian Nordic A/S: Bavarian Nordic - Transactions in Connection with Share Buy-Back Program10
27.03.Bavarian Nordic A/S: Bavarian Nordic Submits Data to EMA to Extend Mpox and Smallpox Vaccine Approval to Children Aged 2-11 Years620Submission based on topline data from clinical study, demonstrating a comparable safety profile and a non-inferior immune response for MVA-BN in children aged 2-11 years compared to adults. COPENHAGEN...
► Artikel lesen
24.03.Bavarian Nordic A/S - Notice Convening Annual General Meeting6
23.03.Bavarian Nordic A/S: Bavarian Nordic - Transactions in Connection with Share Buy-Back Program9
16.03.Bavarian Nordic A/S: Bavarian Nordic - Transactions in Connection with Share Buy-Back Program4
12.03.Bavarian Nordic A/S: Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such9
12.03.Bavarian Nordic and SII sign agreement for chikungunya vaccine production15
Weiter >>
81 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1